Global Fabry Disease Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Therapy Type;

Enzyme Replacement Therapy - Agalsidase Beta (Fabrazyme), Agalsidase Alfa (Replagal) and Pegunigalsidase Alfa (PRX-102), Chaperon Therapy - Migalastat (Galafold), Substrate Reduction Therapy - Lucerastat and Venglustat (Ibiglustat), Gene Therapy.

Segmented by Route of Administration;

Oral and Parenteral.

Segmented by Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn798160196 Published Date: July, 2022 Updated Date: August, 2022

Introduction

Global Fabry Disease Therapeutics Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 105.1
2019 111.0
2020 132.0
2021 144.9
2022 145.3
2023 167.5
2024 182.6
2025 194.4
2026 198.8
2027 219.8
2028 247.3

In the year 2021, the Global Fabry Disease Therapeutics Market was valued at USD 1,325.77 million. The size of this market is expected to increase to USD 2,307.72 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 8.2%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapy Type
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Fabry Disease Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Pipeline Analysis/Technological Advancements
    4. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    5. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Fabry Disease Therapeutics Market, By Therapy Type, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Enzyme Replacement Therapy
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Agalsidase Beta (Fabrazyme)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Agalsidase Alfa (Replagal)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Pegunigalsidase Alfa (PRX-102)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Chaperon Therapy
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Migalastat (Galafold)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Substrate Reduction Therapy
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Lucerastat
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Venglustat (Ibiglustat)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Gene Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Fabry Disease Therapeutics Market, By Route of Administration, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Parenteral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Fabry Disease Therapeutics Market, By Distribution Channel, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    4. Global Fabry Disease Therapeutics Market, By Geography, 2019 - 2029 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Amicus Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Sanofi S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Takeda Pharmaceutical Company Ltd (Shire Plc)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Idorsia Pharmaceuticals Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Sangamo Therapeutics, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Protalix BioTherapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. AVROBIO, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Resverlogix Corp.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Sigilon Therapeutics, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Greenovation Biotech GmBH
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      11. Biosidus S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      12. Pharming Group N.V.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Endocrinology
Global Growth Hormone Deficiency Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Growth Hormone Deficiency Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Hematology
Global Hemophilia A and B Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Hemophilia A and B Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Latest In Healthcare Oncology
Global Immune Checkpoint Inhibitors Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Immune Checkpoint Inhibitors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Infant Nutrition
Global Infant Nutrition Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Infant Nutrition Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...